Nucleosides drive histiocytosis in SLC29A3 disorders by activating TLR7
T. Shibata, M. Taoka, S.-I. Saitoh, Y. Yamauchi, Y. Motoi, M. Komine, E. Fujita, R. Sato, H. Sagara, T. Ichinohe, M. Kawazoe, C. Kato, K. Furusho, Y. Murakami, R. Fukui, M. Ohtsuki, U. Ohto, T. Shimizu, N. Yoshida, T. Isobe, K. MIYAKE
Abstract
A lysosomal transmembrane protein SLC29A3 transports nucleosides from lysosomes to the cytoplasm. Loss-of-function mutations of the SLC29A3 gene cause lysosomal nucleoside storage in monocyte/macrophages, leading to their accumulation called histiocytosis in humans and mice. Little is known, however, about a mechanism behind nucleoside-dependent histiocytosis. TLR7, an innate immune sensors for single stranded RNA, bind and respond to nucleosides. We here show that they drive nucleoside-mediated histiocytosis. Patrolling monocyte/macrophages accumulate in the spleen of Slc29a3-/- mice but not Slc29a3-/- Tlr7-/- mice. Accumulated patrolling monocyte/macrophages stored nucleosides derived from cell corpse. TLR7 was recruited to phagosomes and activated as evidenced by TLR7-dependent phagosomal maturation. TLR7 induced hyper-responsiveness to M-CSF in Slc29a3-/- monocyte/macrophages. These results suggest that TLR7 drives histiocytosis in SLC29A3 disorders. One Sentence SummarySLC29A3 disorders are caused by activation of TLR7 with accumulated nucleosides in lysosomes.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TLR7/8 stress response drives histiocytosis in SLC29A3 disorders
K. Miyake, T. Shibata, … T. Taguchi·bioRxiv·Oct 27, 2022
- The lysosomal carrier SLC29A3 supports anti-bacterial signaling and promotes autophagy by activating TRPML1 in mouse dendritic cells
Daniel J. Netting, Cynthia López‐Haber, … Adriana R. Mantegazza·bioRxiv·Jun 11, 2025
- Endosome dysfunction leads to gain-of-function TLR7 and human lupus
H. Mishra, C. Schlack-Leigers, … O. Majer·bioRxiv·Apr 3, 2023
- SLC15A4 controls endolysosomal TLR7-9 responses by recruiting the innate immune adaptor TASL.
H. Zhang, L. Bernaleau, … M. Rebsamen·bioRxiv·Mar 27, 2023
- Unc93b1 recruits Syntenin-1 to dampen TLR7 signaling and prevent autoimmunity
- NLRP3 Cys126 palmitoylation by ZDHHC7 Promotes Inflammasome Activation
Tao Yu, Dan Hou, … Hening Lin·Cell ReportsPeer-reviewed·Apr 1, 2024